Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 17 min ago
Peer-reviewedCC BYFrontiers in immunology

Efficacy and specific toxicity profiles of GPRC5D- versus BCMA-targeted bispecific antibodies in relapsed/refractory multiple myeloma: a meta-analysis of clinical trials and real-world studies

  • Jiahao Ji1
  • Xinyu Zhao1
  • Bin Wang1
  • Jiayu Li2
  • Fangliang Zhou1
  1. 1Medical School, Hunan University of Chinese Medicine , ,
  2. 2Acupuncture, Tuina and Rehabilitation College, Hunan University of Chinese Medicine , ,
Read full textPDFCite

Related

  1. Bispecific antibodies targeting TL1A and IL-12/23p40 suppress pathogenic Th1/Th17 responses and ameliorate colitis in mice
    Xia Li, Hao Peng, Feng Hao +3
    iSciencePeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCell PressCrossrefEurope PMC
  2. Rapid purity and charge-variant analysis of bispecific antibodies using microfluidic capillary electrophoresis-mass spectrometry
    Ruben Cageling, Karin Lubbers-Geuijen, Govert W. Somsen +1
    Analytical and Bioanalytical ChemistryPeer-reviewedCC BY 4.0Full textImmunologyPMC
  3. 883 A novel CDH17/HER3 bispecific ADC demonstrates superior preclinical efficacy in colorectal cancer
    Yuelei Shen, Yiqing Hu, Xueyuan Jiang +2
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
  4. Bispecific VSV-G Engagers: A Platform for Cell-Type-Specific Delivery of Viral Vectors
    G. N. Nenavath, D. Gataulin, M. Eisenstein +15
    bioRxivPreprintAll rights reservedFull textCell biologybioRxiv
  5. Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics
    T. Vazquez, M. Cuevas-martinez, N. Billiald +19
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv

Cite

BibTeXRIS
BibTeX
@article{ji2026efficacy,
  title = {{Efficacy and specific toxicity profiles of GPRC5D- versus BCMA-targeted bispecific antibodies in relapsed/refractory multiple myeloma: a meta-analysis of clinical trials and real-world studies}},
  author = {Jiahao Ji and Xinyu Zhao and Bin Wang and Jiayu Li and Fangliang Zhou},
  journal = {Frontiers in immunology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13658498},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Efficacy and specific toxicity profiles of GPRC5D- versus BCMA-targeted bispecific antibodies in relapsed/refractory multiple myeloma: a meta-analysis of clinical trials and real-world studies
AU  - Jiahao Ji
AU  - Xinyu Zhao
AU  - Bin Wang
AU  - Jiayu Li
AU  - Fangliang Zhou
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in immunology
UR  - https://europepmc.org/article/PMC/PMC13658498
SN  - 1664-3224
ER  -